GE HealthCare Technologies Inc. (NASDAQ:GEHC) is Chapman Investment Management LLC’s 9th Largest Position

Chapman Investment Management LLC boosted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.4% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 83,071 shares of the company’s stock after buying an additional 292 shares during the quarter. GE HealthCare Technologies comprises approximately 4.8% of Chapman Investment Management LLC’s portfolio, making the stock its 9th biggest holding. Chapman Investment Management LLC’s holdings in GE HealthCare Technologies were worth $6,494,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. LGT Financial Advisors LLC boosted its stake in shares of GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after acquiring an additional 251 shares during the last quarter. Ashton Thomas Securities LLC purchased a new position in GE HealthCare Technologies in the 3rd quarter valued at $26,000. Capital Performance Advisors LLP acquired a new stake in GE HealthCare Technologies during the 3rd quarter worth $26,000. Darwin Wealth Management LLC purchased a new stake in shares of GE HealthCare Technologies during the third quarter worth $31,000. Finally, Continuum Advisory LLC raised its position in shares of GE HealthCare Technologies by 101.8% in the third quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after buying an additional 168 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

GEHC has been the topic of a number of recent research reports. Citigroup boosted their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their price target for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Finally, Wells Fargo & Company lifted their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and a consensus price target of $97.67.

GE HealthCare Technologies Price Performance

NASDAQ:GEHC opened at $92.67 on Wednesday. GE HealthCare Technologies Inc. has a 52 week low of $74.51 and a 52 week high of $94.80. The stock’s fifty day moving average is $84.45 and its two-hundred day moving average is $85.67. The company has a market capitalization of $42.38 billion, a P/E ratio of 21.40, a P/E/G ratio of 3.05 and a beta of 1.15. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19. The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. Equities analysts expect that GE HealthCare Technologies Inc. will post 4.66 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 14th were given a dividend of $0.035 per share. The ex-dividend date was Tuesday, January 14th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.15%. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.23%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.